Format

Send to

Choose Destination
Nephrol Dial Transplant. 2017 Jul 1;32(7):1114-1127. doi: 10.1093/ndt/gfx080.

Clinical practice recommendations for treatment with active vitamin D analogues in children with chronic kidney disease Stages 2-5 and on dialysis.

Author information

1
Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
2
Ghent University Hospital, Ghent, Belgium.
3
Gazi University Hospital, Ankara, Turkey.
4
Ospedale San Paolo, Department of Health Sciences, University of Milan, Milan, Italy.
5
Hopital Femme Mere Enfant, Lyon University, Bron, France.
6
Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy.
7
"A. and P. Kyriakou" Children's Hospital, Athens, Greece.
8
Ghent University, Utopaed, Belgium.
9
Servicio de Nefrología Pediátrica, Hospital Universitari Vall d'Hebron, Barcelona, España.
10
KfH Pediatric Kidney Center, Marburg, Germany.
11
Children's Hospital, Hannover, Germany.
12
Center for Pediatric and Adolescent Medicine, Heidelberg, Germany.

Abstract

In patients with chronic kidney disease (CKD), renal synthesis of active vitamin D [1,25-dihydroxyvitamin D (1,25(OH)2D)] declines and is associated with hypocalcaemia, secondary hyperparathyroidism and the spectrum of CKD-mineral and bone disorder (MBD). In advanced CKD, active vitamin D analogues, including alfacalcidol, calcitriol and paricalcitol, are routinely administered. There are few studies on the use of vitamin D analogues in children with CKD and on dialysis. It is difficult to define bone-specific outcomes that can guide treatment with active vitamin D analogues in children with CKD-MBD. A core working group (WG) of the European Society for Paediatric Nephrology (ESPN) CKD-MBD and Dialysis WGs has developed recommendations for the use of active vitamin D therapy in children with CKD and on dialysis. A second document in parallel with this one covers treatment recommendations for native vitamin D therapy. The WGs have performed an extensive literature review to include systematic reviews and randomized controlled trials in adults and children with CKD and prospective observational studies in children with CKD. The Grading of Recommendation, Assessment, Development and Evaluation (GRADE) system was used to develop and grade the recommendations. In the absence of applicable study data, the opinion of experts from the ESPN CKD-MBD and Dialysis WGs is provided, but clearly GRADE-ed as such and must be carefully considered by the treating physician and adapted to individual patient needs as appropriate.

KEYWORDS:

CKD-MBD; chronic kidney disease (CKD); dialysis; pediatrics; vitamin D

PMID:
28873971
PMCID:
PMC5837664
DOI:
10.1093/ndt/gfx080
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center